Spyros Deftereos, MD, PhD (Neurologist)

Dr Deftereos is the head of the Neurology-Neurophysiology Practice. Dr Deftereos completed his studies in the School of Medicine, University of Athens and specialized in Neurology at the Athens General Hospital “G. Gennimatas”. During his training he gave particular emphasis to Clinical Neurophysiology and he conducted research work on Transcranial Magnetic Stimulation, focusing on the pre- and post- surgical evaluation of Cervical Myelopathy. Dr Deftereos completed his PhD at the University of Athens, on medical informatics.

He is currently the Medical Director of Merck for Greece & Cyprus, while he was the SVP for Drug Discovery at Biovista, a Greek-American company that specializes in (drug repositioning) and Adverse Event prediction.

Dr Deftereos publishes extensively in Clinical Neurophysiology and Biomedical Informatics. He is a reviewer for several international journals in these fields. He is a scientific associate of the 2nd Neurology Department, Aristotle University of Thessaloniki.

Spyros N Deftereos – Curriculum Vitae

Research Interests

Education

  • PhD in Biomedical Informatics (1997 – 2002)

University of Athens, School of Medicine

  • MD (1990 – 1996)

University of Athens, School of Medicine

Medical Specialization

  • 12-month rural service at the Greek island of Lesvos (1997-1998)
  • 9-month specialization in Internal Medicine (2000 – 2001)

General Hospital of Thebes, department of Internal Medicine

  • 6-month Specialization in Psychiatry (2001 – 2002)

Greek Red Cross hospital, department of Psychiatry

  • 6-month Specialization in Psychiatry (2002 – 2003)

Psychiatric hospital of the Greek Armed Forces

  • Specialization in Neurology (2004 – 2008)

Athens General Hospital “G. Gennimatas”, deparment of Neurology

Reviewer for International Journals

  • Muscle and Nerve
  • Journal of the American Medical Association (JAMA)
  • Journal of the Neurological Sciences
  • Neurosurgery
  • Artificial Intelligence in Medicine (Artif Intell Med)
  • European Journal of Neurology (Eur J Neurol)
  • Drug Discovery Today
  • Computer Standards & Interfaces(CSI)
  • Journal of Clinical Neurophysiology
  • WIREs Systems Biology and Medicine
  • Expert Reviews of Clinical Pharmacology
  • Combinatorial Chemistry & High Throughput Screening
  • Interdisciplinary Sciences: Computational Life Sciences
  • Frontiers Pharmacology
  • Clinical Neurology and Neurosurgery
  • Cureus Journal of Medical Science

Professional Associations

  • American Academy of Neuromuscular & Electrodiagnostic Medicine (AANEM)
  • Hellenic Neurology Associations
  • Hellenic Society for Clinical Neurophysiology
  • Athens Medical Association

Participation in Research Projects

  • “Identification of Drug Repurposing Opportunities for the Treatment of Chronic Fatigue Syndrome”. Principal Investigator. The CFIDS Association of America. 2012-2013.
  • “VSAT Network for Telematics and Health Care”
  • “HERMES – Telematic HEalthcare – Remoteness and Mobility Factors in Common European Scenarios”

Patents

  • EP09832613 – Methods for treating Multiple Sclerosis Using Tetracyclic Pyrazinoindoles. Granted, 2015.
  • EP2340254 – Compositions and methods for treating Epilepy. Granted, 2014.
  • AUSTRALIAN PATENT No 2009324495 – Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles. Granted, 2015.
  • US Patent 13/993741 – Compositions and methods for cancer treatment. Granted 2017.
  • US Patent 14/924986 – Compositions and methods for treating mitochondrial diseases. Granted 2017.

Publications

Book Chapters

  • Spyros Deftereos. Motor Neuron Disease: Clinical and Neurophysiology Evaluation. In: Neurosonography of the peripheral nervous system. Beta Medical Publications, February 2024. 
  • Spyros Deftereos. Muscle & Nerve Atlas. In: Electroneurography & Electromyography, from theory to practice. Beta Medical Publications, July 2021
  • Spyros Deftereos. Cervical Radiculopathies. In: Electroneurography & Electromyography, from theory to practice. Beta Medical Publications, July 2021
  • Spyros Deftereos. Special topics on the differential diagnosis of radiculopathies. In: Electroneurography & Electromyography, from theory to practice. Beta Medical Publications, July 2021
  • Spyros N Deftereos, Aris Persidis, Andreas Persidis, Eftychia Lekka, Christos Andronis, Vassilis Virvillis. Systematic Drug Repositioning. In: Joe Dudley and Laura Berliocchi eds. Drug Repositioning: Approaches and Applications for Neurotherapeutics. Taylor & Francis. Published June 2017. ISBN: 978-1482220834
  • Christos Andronis, Anuj Sharma, Spyros Deftereos, Vassilis Virvilis, Ourania Konstanti, Andreas Persidis and Aris Persidis. Mining Scientific and Clinical Databases to Identify Novel Uses for Existing Drugs. In: Michael Barratt and Donald Frail. Drug Repositioning – Bringing New Life to Shelved Assets and Existing Drugs. John Wiley & Sons, 2012.
  • Dr Deftereos is the editor of the Research Topic “Three decades of Transcranial Magnetic Stimulation – current state of the art in the diagnosis and treatment of CNS diseases“, published by Frontiers.

Peer-reviewed journals

Immunology – Biomedical Informatics
  1. Spyros N. Deftereos, George D. Vagougios, Christos Bakirtzis, George Hadjigeorgiou and Nikolaos Grigoriadis. Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the ImmuneSynapse: A Systematic Review. Current Pharmaceutical Design, 2024 Feb 9.  doi: 10.2174/0113816128288102240131053205. Online ahead of print.
  2. SN Deftereos, D Georgonikou. Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review. Ann Onc [Online ahead of print]. DOI: 10.1016/j.annonc.2020.12.001
  3. Gronich N, Deftereos SN, Lavi I, Persidis A, Abernethy D, Rennert G. Hypothyroidism and Subclinical Hypothyroidism are Risk Factors for the Development of Statin-Associated Diabetes Mellitus: A Cohort study. Diabetes Care. Jun 12, 2015 [e-pub]
  4. Deftereos SN, Kechagias E, Ioakeimidou C, Georgonikou D. Transcranial Magnetic Stimulation but not MRI predicts long-term clinical status in cervical spondylosis: a case series. Spinal Cord 2015;53:S16-S18.
  5. Lekka E, Deftereos SN, Persidis A, Persidis A, Andronis C. Literature analysis for systematic drug repurposing: a case study from Biovista. Drug Discovery Today. doi:10.1016/j.ddstr.2011.06.005
  6. Deftereos SN, Andronis C. Is a single type of data sufficient for accurate computational drug repositioning? Science Translational Medicine. Available at: http://stm.sciencemag.org/content/3/96/96ra76/reply#scitransmed_el_444
  7. Deftereos SN, Panagopoulos G, Georgonikou D, Karageorgiou C, Karageorgiou E, Piadites G. Treatment of Idiopathic Intracranial Hypertension: is There a Place for Octreotide? Cephalalgia 2011 Dec;31(16):1679-80.
  8. Andronis C, Sharma A, Virvilis V, Deftereos S, Persidis A. Literature mining, ontologies and information visualization for drug repurposing. Brief Bioinform. 2011; 12(4):357:368.
  9. Spyros N Deftereos, Christos Andronis, Ellen J Friedla, Aris Persidis and Andreas Persidis. Drug repurposing and adverse event prediction using high-throughput literature analysis. Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2011;3(3):323-334.
  10. Gritzalis S., Lambrinoudakis C., Lekkas D., Deftereos S. Technical Guidelines for Enchancing Privacy and Data Protection in Modern Electronic Medical Environments. IEEE Transaction on Information Technology In Biomedicine, Vol. 9, No. 3, September 2005.
  11. Deftereos S., Georgonikou D., Persidis A., Andronis C., Aessopos A. Ιdentification of echocardiographic indices for the early detection of cardiac dysfunction in beta-thalassemia via self-organizing maps: a data exploration study. Med Inform Inter Med Mar 2005; 30(1):37-53.
  12. Defteraios S., Lambrinoudakis C., Gritzalis D. High Level Security Policies for Health: from Theory to Practice. Stud Health Technol Inform. 2004;103:416-23.
  13. Andreas Persidis, Spyros Deftereos, Aris Persidis. Systems Literature Analysis. Pharmacogenomics 2004; 5(7): 943-947.
  14. Deftereos S., Lambrinoudakis C., Gritzalis S., Georgonikou D., Andriopoulos P., Aessopos A. A macro-directive mechanism that facilitates automatic updating and processing of the contents of Electronic Healthcare Records: an extension to the CEN architecture Med Inform Internet Med. 2003 Mar; 28(1):21-41
  15. Deftereos S., Lambrinoudakis C., Andriopoulos P., Farmakis D., Aessopos A., A Java-based Electronic Healthcare Record software for beta-Thalassaemia, Journal of Medical Internet Research 2001;3(4):e33, URL: http://www.jmir.org/2001/4/e33/Neurl
 
Neurology – Clinical Neurophysiology 
  1. Georgios Tsivgoulis, Spyros Deftereos, Claudio Gobbi, Elisabeth Gulowsen Celius, Alina Kulakowska, Giorgia Maniscalco, Irene Mendes, Nicolaos Grigoriadis. Oral Cladribine in patients that change from first-line disease modifying treatments for multiple sclerosis: protocol of a prospective effectiveness and safety study (CLAD CROSS). J CNS Disease. 2022 Apr 1;14:11795735211069441. doi: 10.1177/11795735211069441.
  2. Alexoudi A, Deftereos SN. CGRP Antagonists: Side Effects and Potential Parkinson’s Disease Development. Headache 2020; https://doi.org/10.1111/head.13770
  3. Deftereos SN, Koutlas E, Koutsouraki E, Kyritsis A, Papathanassopoulos P, Fakas N, Tsimourtou V, Vlaikidis N, Tavernarakis A, Voumvourakis K, Arvanitis M, Sakellariou D, DeLorenzo F. Seasonal adherence to and effectiveness of subcutaneous interferon β1-a administered by RebiSmart(tm) in patients with relapsing multiple sclerosis: results of the 1-year observational GEPAT-SMART study. BMC Neurol. 2018 Nov 6;18(1):186.
  4. Alexoudi Athanassia, Patrikellis Panayiotis, Theodoros Fasilis, Deftereos Spyros, Sakas Damianos, Gatzonis Stylianos. Effects of anodal tDCS on motor and cognitive function in a patient with Multiple System Atrophy. Disabil Rehabil. 2018 Oct 21:1-5.
  5. Spyros N Deftereos. B cells in the pathophysiology of myasthenia gravis: Is there a role for cladribine? Muscle & Nerve. 2018;Aug 14 [e-pub].
  6. Spyros N Deftereos. Estimation of Reference Intervals for Transcranial Magnetic Stimulation derived parameters via the Hoffman Indirect Method. Muscle & Nerve. 2018;July 25 [e-pub].
  7. Spyros N Deftereos.  Abnormal Central Motor Conduction at the upper but not lower limbs correlates with severe Cervical Spondylosis: discussion of an unexpected observation. Spinal Cord Ser Cases. 2017 Mar 16;3:17009. doi: 10.1038/scsandc.2017.9. eCollection 2017.
  8. Spyros N Deftereos, Dimitra Georgonikou. Severe, drug-resistant OCD, successfully treated by rTMS and concomitant multidisciplinary psychotherapy. Its not only about the coil. The Primary Care Companion for CNS Disorders. Prim Care Companion CNS Disord. 2017 Apr 20;19(2). doi: 10.4088/PCC.16l02020.
  9. Spyros N Deftereos, Suzanne D Vernon, Andreas Persidis. Current Therapeutic Strategies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: results of an on-line Survey. Fatigue: Biomedicine, Health & Behaviour. 2016;4(1):39-51.
  10. Deftereos SN. Diagnostic TMS is an incredible tool. MagVenture News 6;July 2015. Available at: http://viewer.zmags.com/publication/7e40f8a9#/7e40f8a9/1
  11. Spyros N Deftereos, Evie Dodou, Christos Andronis and Aris Persidis. From Depression to Neurodegeneration and Heart Failure: Re-examining the Potential of MAO Inhibitors. Expert Rev Clin Pharmacol. 2012 Jul;5(4):413-25.
  12. Spyros N Deftereos and Christos A Andronis. “Discordant effects of rasagiline doses in Parkinson disease”. Nature Reviews in Neurology 2010; 6(7):doi:10.1038/nrneurol.2010.2-c1
  13. Deftereos SN, Kechagias EA, Panagopoulos G, Seretis A, Orphanidis G, Antoniou E, Georgakoulias N, Karageorgiou CE. Localization of Cervical Spinal Cord Compression by TMS and MRI. Functional Neurology. 2009;24(2):99-105.
  14. Eleftheriadou A, Deftereos SN, Zarikas V, Panagopoulos G, Sfetsos S, Karageorgiou C, Ferekidou E, Kandiloros D, Korres S. The diagnostic value of earlier and later components of Vestibular Evoked Myogenic Potentials (VEMP) in Multiple Sclerosis. Journal of Vestibular Research 19 (2009) 59–66.
  15. Eleftheriadou, Anna; Deftereos, Spyros; Zarikas, Vasilios; Panagopoulos, Grigoris; Sfetsos, Sotirios; Karageorgiou, Klimentini; Ferekidou, Elisa; Korres, Stavros; Kandiloros, Dimitrios. Test-retest reliability of p13n23 and n34p44 components of Vestibular Evoked Myogenic Potentials (VEMP) in a large healthy population. J Otolaryngol Head Neck Surg 2009;38(4):462-467.
  16. Deftereos SN, Panagopoulos G, Georgonikou D, Eleftheriadou A, Sfetsos S, Karageorgiou E, Karageorgiou CE. The contribution of Vestibular Evoked Myogenic Potentials in localizing brainstem lesions. A preliminary report. B-ENT 2008;4(4): 215-219.
  17. Deftereos SN, Panagopoulos G, Georgonikou D, Karageorgiou E, Andriopoulos P, Karageorgiou CE. On the calculation of Transcallosal Conduction Time, via Transcranial Magnetic Stimulation. Functional Neurology 2008; 23(3):137-140.
  18. Eleftheriadou A, Deftereos SN, Zarikas V, Panagopoulos G, Korres S, Sfetsos S, Karageorgiou KL, Ferekidou E, Kandiloros D. Vestibular evoked myogenic potential eliciting in normal subjects: comparison of four different methods. J Otolaryngol Head Neck Surg. 2008 Oct;37(5):704-11.
  19. Deftereos SN, Panagopoulos G, Georgonikou D, Karageorgiou E, Kefalou P, Karageorgiou CE. Diagnosis of non-organic monoplegia with single pulse Transcranial Magnetic Stimulation. The Primary Care Companion to The Journal of Clinical Psychiatry 2008; 10(5):414.
  20. Deftereos SN, Panagopoulos G, Georgonikou D, Karageorgiou CE. Diagnosis and management of non-organic paraplegia with Transcranial Magnetic Stimulation. Br J Psychiatry 2007; 190: 81-a. URL: http://bjp.rcpsych.org/cgi/eletters/190/1/81-a#7030
  21. Panagopoulos GN, Deftereos SN, Tagaris GA, Grillia M, Kounadi T, Karamani O, Panagiotidis D, Koutiola-Pappa E, Karageorgiou CE, Piadites G. Octreotide: a therapeutic option for Idiopathic Intracranial Hypertension. Neurology, Neurophysiology and Neuroscience 2007:1 (July 10, 2007)
  22. Deftereos S N, Panagopoulos G, Gryllia M, Georgonikou D, Polyzoi M, Kechagias E, Aessopos A, Karageorgiou C E. Neurophysiological monitoring of brainstem function in a patient with Wallenberg syndrome, using Vestibular Evoked Myogenic Potentials. Neurology, Neurophysiology and Neuroscience 2006:3 (June 29, 2006)
  23. Deftereos S, Farmakis D, Papadogianni A, Besleme B, Giakoumis A, Polymeropoylos E, Georgonikou D, Aessopos A. Waldenström’s Macroglobulinemia developing in a patient with Multiple Sclerosis: coincidence or association? Multiple Sclerosis. Multiple Sclerosis, 1 October 2004, vol. 10, no. 5, pp. 598-600(3)
  24. Deftereos SN. Molecular docking cannot accurately predict drug off-target effects: implications for the role of voriconazole in the exacerbation of myasthenia gravis. Muscle & Nerve. 2014 Jan;49(1):147-8.
Other
  1. Fragoulakis V, Mantis A, Christoforidis N, Dovas D, Deftereos S, Lainas T, Mantoudis E, Paraschos A, Sakellariou D, Makrakis E. Follitropin Alpha for assisted reproduction: an analysis based on a non-interventional study in Greece. Curr Med Res Opin. 2022 Oct 13;1-9.
  2. Aessopos A, Kati M, Farmakis D, Polonifi E, Deftereos S, Tsironi M. Intensive Chelation Therapy in beta-Thalassemia and Possible Adverse Cardiac Effects of Desferrioxamine. Int J Hematol. 2007 Oct;86(3):212-5.
  3. Athanassios Aessopos, Spyros Deftereos, Maria Tsironi, Fotios Karabatsos, Jacqueline Yousef, Christina Fragodimitri, Antonia Hatziliami, and Markissia Karagiorga. Predictive echo- doppler indices Of left ventricular impairment in β-thalassemic patients. Annals of Hematology 2007;Jan 30
  4. Tsironi M, Korovesis K, Farmakis D, Deftereos S, Aessopos A. Hypocalcemic heart failure in thalassemic patients. Int J Hematol. 2006 May;83(4):314-7.
  5. Andriopoulos P, Tsironi M, Deftereos S, Aessopos A, Assimakopoulos G. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis. 2007 Jan;11(1):52-7.
  6. Tsironi M, Polonifi K, Deftereos S, Farmakis D, Andriopoulos P, Moyssakis I, Aessopos A. Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia. Eur J Haematol. 2005 Oct;75(4):355-358.
  7. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Polonifi A, Moyssakis I, Diamanti-Kandaraki E, Papalambros E. Cardiovascular effects of splenomegaly and splenectomy in B-thalassemia. Ann Hematol. 2005 Jun;84(6):353-7.
  8. Farmakis D, Polonifi A, Deftereos S, Tsironi M, Papaioannou I, Aessopos A. Aortic valve replacement in a patient with thalassemia intermedia. Ann Thorac Surg. 2006 Feb;81(2):737-9.
  9. Farmakis D, Polymeropoulos E, Polonifi A, Deftereos S, Giakoumi X, Floudas H, Grapsa A, Aessopos A. Myelodysplastic syndrome associated with multiple autoimmune disorders. Clin Rheumatol. 2005 Apr 13.
  10. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, Karagiorga M. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest. 2005 May;127(5):1523-30.
  11. Stergios Tassiopoulos, Spyros Deftereos, Kostas Konstantopoulos, Dimitris Farmakis, Maria Tsironi, Michalis Kyriakidis, Athanassios Aessopos. Does Heterozygous beta-Thalassemia Confer a Protection Against Coronary Artery Disease? Ann. N.Y. Acad. Sci. 1054: 467–470 (2005)
  12. Tsironi M, Ladis V, Margellis Z, Deftereos S, Kattamis Ch, Aessopos A. Impairment of cardiac function in a successful full-term pregnancy in a homozygous beta-thalassemia major: does chelation have a positive role? Eur J Obstet Gynecol Reprod Biol. 2005 May 1;120(1):117-8.
  13. Tsironi M, Deftereos S, Andriopoulos P, Farmakis D, Meletis J, Aessopos A. Reversal of heart failure in thalassemia major by combined chelation therapy: a case report. Eur J Haematol. 2005 Jan;74(1):84-5.
  14. Athanasios Aessopos, Spyros Deftereos, Dimitrios Farmakis, Costas Corovesis, Stergios Tassiopoulos, Maria Tsironi, Dimitra Georgonikou, John Moyssakis. Cardiovascular Adaptation To Chronic Anemia In The Elderly: An Echocardiographic Study. Clin Invest Med. 2004 Oct;27(5):265-73.
  15. Aessopos A, Farmakis D, Sotirchos G, Tsironi M, Deftereos S, Tassiopoulos S, Konstantopoulos K, Rombos J. Hemodynamic assessment of splenomegaly in beta-thalassemia patients undergoing splenectomy. Ann Hematol. 2004 Dec;83(12):775-8. Epub 2004 Aug 26.
  16. Tsironi M, Andriopoulos P, Xamodraka E, Deftereos S, Vassilopoulos A, Asimakopoulos G, Aessopos A. The patient with rhabdomyolysis: have you considered quail poisoning? CMAJ. 2004 Aug 17;171(4):325-6.
  17. Tsironi M, Korovesis K, Farmakis D, Deftereos S, Aessopos A. Hypoparathyroidism and heart failure in thalassemic patients: a case report. Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:310-2.
  18. Farmakis D, Deftereos S, Giakoumis A, Polymeropoulos E, Aessopos A. Rupture of chordae tendineae in patients with β-thalassemia. Eur J Haematol 2004;72:1-3.
  19. Farmakis D., Moyssakis I., Perakis A., Rombos Y., Deftereos S., Giakoumis A., Polymeropoulos E., Aessopos A. Unstable angina associated with coronary arterial calcification in a thalassemia intermedia patient with a pseudoxanthoma elasticum-like syndrome. Eur J Haematol 2003; 70(1): 64-66
  20. Aessopos A., Tsironi M., Vassiliadis I., Farmakis D., Fountos A., Voskaridou E., Perakis A., Defteraios S., Loutradi A., Loukopoulos D., Exercise-induced Myocardial Perfusion Abnormalities in Sickle β-Thalassemia: Tc-99m Tetrofosmin Gated SPECT Imaging Study, Am J Med. 2001 Oct 1;111(5):355-60
  21. Deftereos S., Fractal dimensions of human brain cortex vessels during the fetal period, Medical Science Monitor, letter to the editor, MedSciMonit, 2002; 8(5): 13-14, http://medscimonit.com/medscimonit/modules.php?name=Current_Issue&vol_all=8&no_all=5
Peer-reviewed conferences
  1. Giorgia Teresa Maniscalco, Alina Kulakowska, Elisabeth Gulowsen Celius, Claudio Gobbi, Irene Mendes, Maria Leftherioti, Celine DelGrande, Shatha Sayegh, Spyros Deftereos, Nicolaos Grigoriadis. Switch to oral cladribine from first line DMD in MS: 2nd Interim Analysis of CLAD CROSS. European Academy of Neurology Congress, 2023, Budapest, Hungary. Accepted for Publication.
  2. Giorgia Teresa Maniscalco, Alina Kulakowska, Elisabeth Gulowsen Celius, Claudio Gobbi, Irene Mendes, Maria Leftherioti, Celine DelGrande, Shatha Sayegh, Spyros Deftereos, Nicolaos Grigoriadis. Switch to oral cladribine from first line DMD in MS: Interim Analysis of CLAD CROSS. European Charcot Foundation Congress, 2023, Baveno, Italy
  3. SN Deftereos, E Koutlas, E Koutsouraki, A Kyritsis, P Papathanassopoulos, N Fakas, V Tsimourtou, N Vlaikidis, A Tavernarakis, K Voumvourakis, M Arvanitis, D Sakellariou, F DeLorenzo. Evaluation of the Effect of Seasonal Weather Variations on Adherence and Effectiveness of Subcutaneous Interferon b-1a Administered by REBISMART(tm) in Patients with Relapsing Remitting Multiple Sclerosis: Final Results of the 1-year Observational GEPAT-SMART Study. 25th European Charcot Foundation Congress, November 2017, Baveno, Italy.
  4. Spyros N Deftereos, Christos Andronis, Anuj Sharma and Aris Persidis. American Neurological Association, 135th Annual Meeting, 12-15 September, San Fransisco.
  5. Spyros N Deftereos, Christos Andronis, Vassilis Virvillis, Ourania Konstanti and Andreas Persidis. American Neurological Association, 135th Annual Meeting, 12-15 September, San Fransisco.
  6. Eleni Ntouvali, Spyridon Deftereos, Theodoros Filippidis, Michalis Sideris, Grigorios Panagopoulos, Apostolos Papalois, Panagiotis Kinnas. The influence of bFGF and NGF in end-toside neurorraphy of the common peroneal nerve to the tibial nerve in rats. 9th EFORT Congress, 29 May – 1 June 2008 in Nice, France, Free Paper Session Hand and Wrist on Saturday, May 31 2008
  7. Ntouvali E, Deftereos S, Filippidis T, Sideris M, Panagopoulos G, Papalois A, Kinnas P. The role of bFGF and NGF in the treatment of a common-peroneal-nerve gap by means of autologous nerve grafting in rats. 9th EFORT Congress, 29 May – 1 June 2008 in Nice, France
  8. Deftereos SN, Panagopoulos GN, Georgonikou D, Katsarou S, Doumas L, Karageorgiou E, Karageorgiou CE. Repetitive Transcranial Magnetic Stimulation Can Improve Walking in Multiple Sclerosis Patients with Spastic Paraparesis. American Academy of Neurology, Chicago, Illinois, April 12-19 2008.
  9. E Ntouvali, S Deftereos, Th Filippidis, M Sideris, G Panagopoulos, A Papalois, PA Kinnas. The Influence of bFGF and NGF in end-to-side Neurorraphy of the Common Peroneal Nerve to the Tibial Nerve, as well as in the Treatment of a Common-Peroneal-Nerve Gap by Means of Autologous Grafting, in Rats. World Society for Reconstructive Microsurgery. IV Congress, June 24-26 2007, Athens, Greece.
  10. E Ntouvali, S Deftereos, Th Filippidis, M Sideris, G Panagopoulos, A Papalois, PA Kinnas. The Influence of bFGF and NGF in end-to-side Neurorraphy of the Common Peroneal Nerve to the Tibial Nerve in rats. Federation of European Societies for Surgery of the Hand. XII Congress, June 27-30, 2007, Athens, Greece.
  11. A Barbitsioti, I Ignatiadis, A Patralexis, S Defteraios, H Tsolakis, A Papalois, AV Zoubos, PN Soucacos. NGF-S7 Factor Combined with an Epineural Conduit to Bridge Short Nerve Defects. Experimental Study in the Rabbit Nerve. 10th Congress of the International Federation of Societies for Surgery of the Hand. March 11-15 2007, Sydney
  12. A Barbitsioti, I Ignatiadis, A Patralexis, S Defteraios, H Tsolakis, A Papalois, AV Zoubos, PN Soucacos. NGF S7 Promoting Factor administration combined with an Epineural Conduit Technique for Bridging Short Nerve Defects. Combined Annual Meeting with International Participation of the Hellenic Society for Reconstructive Microsurgery and of the Hellenic Society for Surgery of the Hand. Killini, 6-10 September 2006
  13. Eleftheriadou A, Deftereos SN, Panagopoulos G, Chalastras T, Sfetsos S, Karageorgiou CL, Ferekidou E, Kandiloros D, Korres S. The clinical value of earlier and later components of Vestibular Evoked Myogenic Potentials (VEMPs) in Acute acoustic trauma. 6th EUROPEAN CONGRESS OF OTO-RHINO-LARYNGOLOGY, HEAD AND NECK SURGERY (EUFOS)
  14. Deftereos S.N., Panagopoulos G, Kapsalakis I., Georgonikou D., Karageorgiou C.E. Τhe use of vestibular evoked myogenic potentials in the neurophysiologic study of basilar dolichoectasia. J Neurol Suppl 2006 May;Vol 253, Suppl 2: II/46
  15. S Deftereos, G Panagopoulos, D Georgonikou, Ch Petropoulos, V Fili, C E Karageorgiou. Assessment of lower pontine dysfunction by vestibular evoked myogenic potentials. Clinical Neurophysiology 2006 Suppl 1;117:S251
  16. S Deftereos, G Panagopoulos, D Georgonikou, C Boulas, E Karageorgiou, C E Karageorgiou. Transcallosal Conduction Time abnormalities in Multiple Sclerosis patients with lesions of the Corpus Callosum. 58th Annual Meeting of the American Academy of Neurology, San Diego, Callifornia, April 1-8 2006
  17. S. Deftereos, G. Panagopoulos, A. Eleftheriadoy, M. Polyzoi, D. Korakaki, S. Sfetsos, D. Georgonikou, C.H. Boulas, C.E. Karageorgiou. The use of vestibular evoked myogenic potentials in multiple sclerosis patients. Multiple Sclerosis Vol 11 Suppl 1;S64
  18. M. Polyzoi, S. Deftereos, C. Giannoulis, A. Sarafianos, G. Panagopoulos, C. Karageorgiou. Hearing loss as a symptom in multiple sclerosis. European Journal of Neurology 12 (Suppl 2): 138
  19. S.N. Deftereos, A. Eleftheriadoy, M. Polyzoi, D. Korakaki, S. Sfetsos, G. Panagopoulos, D. Georgonikou, C.H. Boulas, C.E. Karageorgiou. The use of vestibular evoked myogenic potentials in multiple sclerosis patients. European Journal of Neurology 12 (Suppl 2): 257
  20. S.N. Deftereos, A. Eleftheriadou, D. Korakaki, J. Papatriantaphylloy, S. Sfetsos, G. Panagopoulos, D. Georgonikou, C. Boulas, E. Karageorgiou, C. Karageorgiou. Vestibular involvement in migraine with aura. European Journal of Neurology 12 (Suppl 2): 257-258
  21. Farmakis D, Karabatsos F, Joussef J, Deftereos S, Polonifi A, Karagiorga M, Aessopos A. Cardiac output in regularly transfused patients with beta-thalassemia. 9th Congress of the European Hematology Association (ΕΗΑ). Geneva, Switzerland, June 10-13, 2004
  22. Deftereos S., Lambrinoudakis C., Gritzalis D. High Level Security Policies for Health: from Theory to Practice in Bos Lodewijk, Laxminarayan Swammy, Marsh Andy. Medical and Care Compunetics 1. IOS Press, pp. 416-423.
  23. Farmakis D., Deftereos S., Moissakis J., Petrou A., Tsironi M., Tassiopoulos S., Georgonikou D., Aessopos A. Electro- And Echo-Cardiographic Assessment of the Effects of Chronic Anemia on the Aged Heart. 8th European Hematology Association Conference, 12-15 June 2003, Lyon, France
  24. Farmakis D., Fragodimitri C., Karabatsos F., Youssef J., Hatziliami A., Deftereos S., Mitilineou E., Karagiorga M., Aessopos A. Cardiac Disease in Well-Treated Patients With Thalassemia Major. 8th European Hematology Association Conference, 12-15 June 2003, Lyon, France
  25. Tsironi M, Korovesis K, Farmakis D, Deftereos S, Aessopos A. Hypothyroidism and heart failure in thalassemic patients: A case report. 9th International Conference on Thalassemia and the Hemoglobinopathies. Palermo, Italy, October 15 – 19, 2003
  26. Berdoukas V., Karabatsos F., Yousef J., Fragodimitri C., Hatziliami A., Deftereos S., Karagiorga M. Determination of the risk of cardiac dysfunction in a large group of severe thalassemia major patients managed homogenously using easily accessible parameters. June 6-9 2002, Florence, Italy.
  27. Farmaki K., Kalliou V., Anagnostopoulos G., Deftereos S. Compliance to Iron Chelation Therapy Achieved by Individually Tailored Treatment. 8th International Conference on Thalassaemia and the Haemoglobinopathies, Athens, Greece, 18 – 21 October 2001
  28. Gotsis E., Farmaki K., Toulas P., Kalliou V., Deftereos S., Aessopos A. Myocardium and Liver Iron Overload in beta-Thalassaemia Patients by Quantitative Magnetic-Resonance-Imaging. 8th International Conference on Thalassaemia and the Haemoglobinopathies, Athens, Greece, 18 – 21 October 2001
  29. Deftereos S., Farmakis D., Farmaki K., Aessopos A. An Electronic Healthcare Record Software for b-Thalassaemia: Initial Experience. 8th International Conference on Thalassaemia and the Haemoglobinopathies, Athens, Greece, 18 – 21 October 2001
  30. Gatzonis M., Deftereos S., Vasiliou P., Dimitriou F., Creatsas C., Sotiriou D., Boddy K. Maternity Telemedicine Services in the Aegean Islands. World Conference on Telemedicine, Toulouse, France, 2000
  31. Deftereos S., Maskens A., Sotiriou D. Integrating Clinical Care Guidelines with Electronic Healthcare Records. Proceedings of the 1999 American Medical Informatics Association Symposium, 1046, (Philadelphia: Hanley&Belfus)
  32. Georgiou E., Virvidakis K., Douskas G., Deftereos S., Proukakis Ch. Body composition changes in elite male wightlifters during a ten month training for international competition. Fifth IOC World Congress on Sport Sciences
  33. Deftereos S., Gatzonis M., Sotiriou D. Telemedicine Services Based on Distributed Electronic Healthcare Records. The 3rd International Conference on the Medical Aspects of Telemedicine, 30 Μαίου – 1 Ιουνίου, Ιαπωνία
  34. Ginis A., Deftereos S., Sotiriou D. Use of Electronic Healthcare Records to Improve Primary Healthcare Services in the Greek Islands. Medical Informatics Europe Conferece ‘96, 19-22 Ιουνίου 1996
Greek journals and conferences
  1. Α. Αλεξούδη, Π. Πρατικέλης, Σ. Δευτεραίος. Θ. Φασίλης, Δ. Καράκαλος, Α. Βερεντζιώτη, Σ. Κορφιάς, Δ. Σακάς, Σ. Γκατζώνης. Διακρανιακή διέγερση συνεχούς ρεύματος (tDCS) σε ασθενείς με Προϊούσα Υπερπυρηνική Παράλυση. Πανελλήνιο Νευροφυσιολογικό Συνέδριο, 2019, Αράχωβα.
  2. Α. Αλεξούδη, Π. Πρατικέλης, Θ. Φασίλης, Σ. Δευτεραίος. Δ. Σακάς, Σ. Γκατζώνης. Διακρανιακή διέγερση συνεχούς ρεύματος (tDCS) σε ασθενή με ατροφία πολλαπλών συσημάτων. Πανελλήνιο Νευρολογικό Συνέδριο, 2018, Κέρκυρα.
  3. Σ. Δευτεραίος, Ε. Κούτλας, Ε. Κουτσουράκη, Α. Κυρίτσης, Π. Παπαθανασόπουλος, Ν. Φάκας, Γ. Χατζηγεωργίου, Ν. Βλαϊκίδης, Α. Ταβερναράκης, Κ. Βουμβουράκης, Μ. Αρβανίτης, Δ. Σακελλαρίου. Ελληνική Επιδημιολογική Μελέτη για την Αξιολόγηση της Συμμόρφωσης των Ασθενών με Πολλαπλή Σκλήρυνση στη Θεραπεία με τη χρήση της συσκευής RebiSMART(tm) και της Επίδρασης Κλιματκών Παραγόντων (Μελέτη GEPAT). Πανελλήνιο Νευρολογικό Συνέδριο 2017, Καλαμάτα.
  4. Σ. Ν. Δευτεραίος, Ε. Α. Κεχαγιάς, Γ. Παναγόπουλος1, Α. Σερέτης, Ν. Γεωργακούλιας, Ε. Αντωνίου, Κ. Ε. Καραγεωργίου. Εντοπισμένος του επιπέδου βλάβης του Αυχενικού Νωτιαίου Μυελού: σύγκριση του Διακρανιακού Μαγνητικού Ερεθισμού με τη Μαγνητική Τομογραφία. 2ο Πανελλήνιο Συνέδριο Σπνυλικής Στήλης, 25-27 Οκτωβρίου 2008, Χαλικιδική.
  5. Ε. Ντούβαλη, Σ. Δευτεραίος, Θ. Φιλιππίδης, Μ. Σιδέρης, Γ. Παναγόπουλος, Α. Παπαλόης, Π.Α. Κίννας. Η επίδραση των αυξητικών παραγόντων bFGF και NGF στην αντιμετώπιση ελλείμματος του κοινού περονιαίου νεύρου με τη χρήση αυτόλογου νευρικού μοσχεύματος σε επίμυες. 64ο Πανελλήνιο Ορθοπαιδικό Συνέδριο.
  6. Ε. Ντούβαλη, Σ. Δευτεραίος, Θ. Φιλιππίδης, Μ. Σιδέρης, Γ. Παναγόπουλος, Α. Παπαλόης, Π.Α. Κίννας. Η Επίδραση των Αυξητικών Παραγόντων bFGF και NGF στην αντιμετώπιση ελλείματος του κοινού περονιαίου νεύρου, με την χρήση αυτόλογου νευρικού μοσχεύματος σε επίμυες. Μετεκπαιδευτικό περιφερειακό Ορθοπαιδικό Σεμινάριο Πελλοπονήσου, Τρίπολη, 23-25 Φεβρουαρίου 2007.
  7. Ε. Ντούβαλη, Σ. Δευτεραίος, Θ. Φιλιππίδης, Μ. Σιδέρης, Γ. Παναγόπουλος, Α. Παπαλόης, Π.Α. Κίννας. Η Επίδραση των Αυξητικών Παραγόντων bFGF και NGF στα Αποτελέσματα της Τελικοπλαγίας Συρραφής του Κοινού Περονιαίου στο Κνημιαίο Νεύρο σε Επιμύες. Ετήσιο Κοινό Συνέδριο Ελληνικής Εταιρείας Επανορθωτικής Μικροχειρουργικής και Ελληνικής Εταιρείας Χειρουργικής Χεριού και Άνω Άκρου, 27 Ιουνίου 2007, Αθήνα.
  8. Ε. Ντούβαλη, Σ. Δευτεραίος, Θ. Φιλιππίδης, Μ. Σιδέρης, Γ. Παναγόπουλος, Α. Παπαλόης, Π.Α. Κίννας. Η Επίδραση των Αυξητικών Παραγόντων bFGF και NGF στην αντιμετώπιση ελλείματος του κοινού περονιαίου νεύρου, με την χρήση αυτόλογου νευρικού μοσχεύματος σε επίμυες. Ετήσιο Κοινό Συνέδριο Ελληνικής Εταιρείας Επανορθωτικής Μικροχειρουργικής και Ελληνικής Εταιρείας Χειρουργικής Χεριού και Άνω Άκρου, 27 Ιουνίου 2007, Αθήνα.
  9. Σ. Ν. Δευτεραίος, Ε. Κεχαγιάς, Γ. Παναγόπουλος, Ν. Γεωργακούλιας, Κ. Ματαλιωτάκης, Γ. Σερέτης, Δ. Γεωργονίκου, Α. Μητρόπουλος, Δ. Σκυτιώτης, Χ. Ιωακειμίδου, Κ. Ε. Καραγεωργίου. Προεγχειρητική και μετεγχειριτική αξιολόγηση αυχενικής μυελοπάθειας, με διακρανιακό μαγνητικό ερεθισμό. 21ο Πανελλήνιο Συνέδριο Νευροχειρουργικής, 16-17 Μαϊου 2007, Ρόδος
  10. Δ. Γεωργονίκου, Σ. Δευτεραίος, Ν. Μαρκετος, Φ. Καψάλη, Σ. Πρασσάς, Π. Γεωργιλά, Δ. Σακκάς. Η Ημιαιμωδία ως σύμπτωμα της Σωματομετατρεπτικής Διαταραχής. 4ο Πανελλήνιο Συνέδριο Ψυχιατρικής των Γενικών Νοσοκομείων.
  11. Σ.Ν. Δευτεραίος, Γ. Παναγόπουλος, Π. Αποστολόπουλος, Μ. Πολυζώη, Χ. Πετρόπουλος, Σ. Βασάκος, Δ. Γεωργονίκου, Κ.Ε. Καραγεωργίου. Προσδιορισμός του επιπέδου της βλάβης του νωτιαίου μυελού σε ασθενείς με αυχενική μυελοπάθεια, με τη βοήθεια του διακρανιακού μαγνητικού ερεθισμού. 20ο Πανελλήνιο Νευρολογικό Συνέδριο. Λάρισα, 16-19 Μαρτίου 2006.
  12. Σ.Ν. Δευτεραίος, Γ. Παναγόπουλος, Ι. Καψαλάκης, Π. Αποστολόπουλος, Κ. Ματαλιωτάκης, Δ. Γεωργονίκου, Κ.Ε. Καραγεωργίου. Η συμβολή των αιθουσαίων προκλητών μυογενών δυναμικών (vemps) στην ηλεκτροφυσιολογική μελέτη ασθενών με δολιχεκτασία βασικής. 20ο Πανελλήνιο Νευρολογικό Συνέδριο. Λάρισα, 16-19 Μαρτίου 2006.
  13. Γιαννούλης Χ., Καργάδου Α., Σαραφιανός Α., Μπουλάς Χ., Σακκού Β., Μπριασούλης Δ., Δευτεραίος Σ., Αποστολόπουλος Π., Παπαγεωργίου Ε., Καραγεωργίου Κ.Ε. Ο Ρολος Και Η Σημασία Της Μονάδας Αυξημένης Φροντίδας Νευρολογικών Ασθενών Σε Ένα Γενικό Νοσοκομείο Στην Αθηνά. Νευρολογία 2005; 14(1):136-156
  14. Σ.Ν. Δευτεραίος, Α. Ελευθεριάδου, Σ. Σφέτσος, Δ. Γεωργονίκου, Γ. Παναγόπουλος, Α.Ρομποτής, Γ. Παπατριανταφύλλου, Λ. Κατσακλής, Ε. Καραγεωργίου, Κ.Ε. Καραγεωργίου. Η Χρήση των Αιθουσαίων Προκλητών Δυναμικών (Vemps)
  15. σε Ασθενείς με Ημικρανία με Αύρα. Νευρολογία 2005; 14(1):120-135
  16. Ηλίας Σ., Κωνσταντοπούλου Α., Περτέση Ε., Μαυρομάτη Ε., Σαββανή Μ., Δευτεραίος Σ. Περιβαλλοντική και υποστηρικτική παρέμβαση στην θεραπεία του τρομώδους παραληρήματος. Εγκέφαλος 2003;40(3):Ιούλιος-Σεπτέμβριος
  17. Ηλίας Σ., Κωνσταντοπούλου Α., Περτέση Ε., Μαυρομάτη Ε., Δευτεραίος Σ., Σαββανή Μ. Θεραπεία τρομώδους παραληρήματος με Διαζεπάμη και Αλοπεριδόλη. Εγκέφαλος 2003;40(2):Απρίλιος-Ιούνιος
  18. Περτέση Ε., Ηλίας Σ., Κουτουβίδης Ν., Πρατικάκης Μ., Κωνσταντοπούλου Α., Δευτεραίος Σ. Ψυχοπαθολογικοί παράγοντες θαλασσαιμικών ασθενών. 17ο Πανελλήνιο Συνέδριο Ψυχιατρικής, 19-23 Απριλίου 2002, Χαλκιδική
  19. Κουτουβίδης Ν., Πρατικάκης Μ., Ηλίας Σ., Δευτεραίος Σ., Σαββανή Μ. Ιεράρχηση προτεραιοτήτων: η θέση και η άσκηση της Ψυχιατρικής στην Ελλάδα. 17ο Πανελλήνιο Συνέδριο Ψυχιατρικής, 19-23 Απριλίου 2002, Χαλκιδική
  20. Κουτουβίδης Ν., Ηλίας Σ., Πρατικάκης Μ., Κωνσταντοπούλου Α., Μαυρομάτη Ε., Δευτεραίος Σ., Σαββανή Μ. Δημιουργία νέων ψυχιατρικών δομών σε γενικό νοσοκομείο: η φιλοσοφία και τα προβλήματά της. 17ο Πανελλήνιο Συνέδριο Ψυχιατρικής, 19-23 Απριλίου 2002, Χαλκιδική
  21. Ηλίας Σ., Κουτουβίδης Ν., Περτέση Ε., Κωνσταντοπούλου Α., Μαυρομάτη Ε., Δευτεραίος Σ. Θεραπεία Τρομώδους Παραληρήματος με Διαζεπάμη και Αλοπεριδόλη. 17ο Πανελλήνιο Συνέδριο Ψυχιατρικής, 19-23 Απριλίου 2002, Χαλκιδική
  22. Γκότσης Ε. Δ., Φαρμάκη Κ., Τούλας Π., Παπαφραγκάκη Δ., Δευτεραίος Σ., Αίσωπος Α. Εκτίμηση της αιμοσιδήρωσης του μυοκαρδίου και ήπατος σε ασθενείς με β-μεσογειακή αναιμία με ποσοτική μαγνητική τομογραφία. Haema 2001, Συμπλήρωμα: 202 – 203
  23. Φαρμάκη Κ., Αναγνωστόπουλος Γ., Παπαφραγκάκη Δ., Δευτεραίος Σ. Βελτίωση της συμμόρφωσης στη θεραπεία αποσιδήρωσης στη μεσογειακή αναιμία. Haema 2001, Συμπλήρωμα: 259 – 260
  24. Δευτεραίος Σ., Παπαφραγκάκη Δ., Φαρμάκης Κ., Φαρμάκη Κ., Αίσωπος Α., Καράγιωργα Μ., Βερδούκας Β. Αρχική εμπειρία από τη χρήση ενός Ηλεκτρονικού Ιατρικού Φακέλου για τη Μεσογειακή Αναιμία. Haema 2001, Συμπλήρωμα: 267 – 268
  25. Δευτεραίος Σ., Αλεξανδρή Ν., Ταμβίσκος Α., Φρυδάς Α., Ψώμου Μ., Σωτηρίου Δ. Ηλεκτρονικοί Ιατρικοί Φάκελοι στην Πρωτοβάθμια Φροντίδα Υγείας: η εμπειρία ενός Κέντρου Υγείας. 24ο Πανελλήνιο Ιατρικό Συνέδριο, 5 – 9 Μαίου 1998, Αθήνα
  26. Γκίνης Α., Δευτεραίος Σ., Σωτηρίου Δ. Δημιουργία Ηλεκτρονικών Ιατρικών Φακέλων των Κατοίκων των Κοινοτήτων Αρκεσίνης και Βρουτσίου Αμοργού. 6ο Πανελλήνιο Συνέδριο Γενικής Ιατρικής, 5 – 8 Μαίου 1996, Χαλκιδική
  27. Παπαδογιάννης Δ., Στούμπος Κ., Δευτεραίος Σ., Σωτηρίου Δ. Χρήση Ηλεκτρονικού Ιατρικού Φακέλου στο Υπερτασικό Ιατρείο. 7ο Πανελλήνιο Συνέδριο Γενικής Ιατρικής, 27 Απριλίου – 1 Μαίου 1995, Πάτρα

Invited Lectures

  • “Basic Principles of Electromyography” in the post graduate course “breathing abnormalities during sleep – laboratory and clinical sleep medicine”, University of Athens, November 2023
  • 11th Annual Congress of the Hellenic Neurophysiology Society, November 2023, Plastira Lake. “Clinical and Laboratyr Investigation of Myasthenia Gravis”
  • 34th Annual Congress of the Hellenic Neurological Society, June 2023, Athens. “Psychiatric Comorbidities of Neuromuscular Disorders” 
  • Greek Neurophysiology Society EMG Workshop, December 2022, Korinthos. “Polyneuropathies – Basic Concepts”.
  • “The use of Transcranial Magnetic Stimulation in other Neurological Diseases”. 10th Annual Congress of the Hellenic Clinical Neurophysiology Society. September 29 – October 1 2022, Porto Heli, Greece
  • “Neurophysiology methods for the detection of central motor neuron lesions in ALS”. 10th Annual Congress of the Hellenic Clinical Neurophysiology Society. September 29 – October 1 2022, Porto Heli, Greece
  • “Autoimmune Polyneuropathies – Therapeutic Advances”. 3rd Panhellenic Congress on Rare Diseases & Orphan Drugs. September 17-17, Tinos, Greece
  • 9th Panhellenic Neurophysiology Congress. “Neurophysiological evaluation of amyloid polyneuropathies”. October 29-31 2021, Athens, Greece.
  • 4th Panhellenic Seminar in Endocrinology. “Diabetic Neuropathy”. September 20-22 2013, Athens, Greece.
  • Tools for Treatment Optimization Based on Predicted Side-Effects. In: Personalized medicine knowledge as a catalyser for medical decision making. EPEMED webinar, 18th June 2014.
  • Panhellenic Conference of Clinical Neurophysiology. “Transcranial Magnetic Stimulation”. Kalamata, Peloponnese, 2015.
  • Instructor at the 2nd EMG Workshop of the Hellenic Neurophysiology Society, December 16-20, 2015, Evoia, Greece.
  • “Multifocal Motor Neuropathy, Miller-Fisher Syndrome and variants”. 8th Education Workshop of the Hellenic Neurology Association. May 2016, Aegina, Greece
  • “The use of Transcranial Magnetic Stimulation in the diagnosis of cervical myelopathy”. 5th Conference of the Hellenic Neurophysiology Society, October 2016, Katerini, Greece.
  • Instructor at the 3nd EMG Workshop of the Hellenic Neurophysiology Society, December 2016, Trikala, Greece.
  • Topics in Clinical Neurology, September 2018, Nafplion. “Cervical Spondylotic Myelopaty”
  • Panehellenic Neurophysiology Congress, October 2018, Crete. “What new in Transcranial Magnetic Stimulation in 2018”.
  • Days of Neurology & Primary Care, March 2019, Patra. “Cervical Spondylotic Myelopathy”.
  • Post Graduate Course “New Drug Development”, University of Athens, April 2020. “From Bench to Bedside: conclusions and consequences of Negative Clinical Trials”.
  • Panhellenic Neyrophysiology Congress, November 2019, Arahova. “Differential Diagnosis of Motor Neuron Disease and Inclusion Body Myositis”.
  • Panhellenic Neyrophysiology Congress, November 2019, Arahova. “Diagnositc and Therapeutic Uses of Transcranial Magnetic Stimulation”.
  • Greek Neurophysiology Society EMG Workshop, December 2019, Ioannina. “Radial Nerve Lesions”.
  • Greek Neurophysiology Society EMG Workshop, December 2019, Ioannina. “Polyneuropathies – Basic Concepts”.
  • Post Graduate Course “New Drug Development”, University of Athens, April 2020. “From Bench to Bedside: conclusions and consequences of Negative Clinical Trials”.
  • Post Graduate Course “New Drug Development”, University of Athens, April 2021. “From Bench to Bedside: conclusions and consequences of Negative Clinical Trials”.
  • Post Graduate Course “Precision Medicine in Neurobiology”, Aristotle University of Thessaloniki, May 2021. “Precision Medicine in Neurology: Data, Methods of Analysis and their Application in the Personalization of Treatment”.
  • “9th International Summer School in Medical Biosciences Research and Management”, World Hellenic Biomedical Association, May 2021. “Identifying Marketable Scientific Discoveries”.

Facebooktwitterredditpinterestlinkedinmail